Intellia Therapeutics Gets New Chief Post author:Sam Post published:December 17, 2017 Post category:BioPharma Intellia has named John Leonard, M.D., President and CEO, effective January 1, 2018. Source: BioSpace You Might Also Like Spark Therapeutics Jumps as FDA Panel Backs Breakthrough Gene Therapy October 12, 2017 Reata Pharmaceuticals, Inc. Announces First Quarter 2017 Financial And Operating Results May 10, 2017 Carmat Expands Its PIVOTAL Study Internationally, In Line With Its Clinical Strategy And CE Marking Process October 5, 2017
Reata Pharmaceuticals, Inc. Announces First Quarter 2017 Financial And Operating Results May 10, 2017
Carmat Expands Its PIVOTAL Study Internationally, In Line With Its Clinical Strategy And CE Marking Process October 5, 2017
